The European Medicines Agency has expressed concern over recent inspection findings where clinical trial sponsors were unable to demonstrate how they qualified/validated the computerized systems that are used for managing trial data.
The inspection findings have prompted the EMA to issue a
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?